Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. NuVasive beats The Street, closes DoJ settlement
NuVasive Inc. posted 2nd-quarter earnings that topped expectations on Wall Street and closed out its $14 million settlement with the U.S. Justice Dept.
San Diego-based NuVasive reported profits of $10.3 million, or 20¢ per share, on sales of $202.9 million for the 3 months ended June 30, marking a swing to profits from losses of -$4.1 million and 6.4% sales growth, compared with Q2 2014. Read more
2. Lombard Medical looks to M&A to grow beyond AorFix
Lombard Medical Technologies CEO Simon Hubbert said the stent graft maker is looking beyond the abdominal aortic aneurysm repair market, aiming to grow out of being a 1-product company either via acquisition or a distribution deal with a larger medical device company.
Discussing Lombard’s 2nd-quarter results July 27, Hubbert referenced the $110 million buyout of Aptus Endosystems by Medtronic, observing that the crowded and competitive abdominal aortic aneurysm repair market is driving consolidation. Read more
1. Meet Warren Robotics, the robot-assisted surgery project from Johnson & Johnson and Google
A ruling by the Competition Commission of India sheds a bit of light on the robot-assisted surgery joint venture between Johnson & Johnson and Google.
New Brunswick, N.J.-based J&J said in March that its Ethicon subsidiary and Google will work on “an innovative robotic-assisted surgical platform capable of integrating advanced technologies with the goal of improving healthcare delivery in the operating room.” Read more
